Dermatology in Public Health Environments pp 367-386 | Cite as
Cutaneous T-Cell Lymphoma and NK Cells
Abstract
Primary cutaneous lymphomas (PCLs) are a group of extranodal non-Hodgkin lymphomas characterized by early accumulation of mononuclear cells, most of them lymphocytes, on skin, with no evidence of extracutaneous disease at diagnosis. T-cell and natural killer (NK) cell lymphomas (CTCL/NK) with an absolute predominance of mycosis fungoides (MF) represent approximately 44% of all PCLs. The etiology and the exact steps in the pathogenesis of CTCL are not understood. It is more reasonable to assume that these diseases represent the endpoint of several different processes. Genetic, environmental, and infectious factors should all be considered in the etiology of CTCL. The current classification for PCLs was proposed in 2005 by the World Health Organization (WHO) and the European Organization for Research and Treatment of Cancer (EORTC). WHO-EORTC Classification for primary cutaneous T- and NK-cell lymphomas is MF and subtypes of MF (folliculotropic MF, pagetoid reticulosis, granulomatous cutis laxa); Sézary syndrome; adult T-cell leukemia/lymphoma; primary cutaneous CD30+ lymphoproliferative diseases (primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis); subcutaneous panniculitis-like T-cell lymphoma; extranodal NK/T-cell lymphoma, nasal type; and primary cutaneous peripheral T-cell lymphoma, unspecified (primary aggressive epidermotropic CD8+ cutaneous T-cell lymphoma, provisional entity; cutaneous γδ T-cell lymphoma, provisional entity; and cutaneous lymphoma of small and medium pleomorphic CD4+ T-cell, provisional entity).
Keywords
Cutaneous T-cell lymphoma Non-Hodgkin lymphoma Mycosis fungoides Sézary syndrome Adult T-cell leukemia/lymphoma Primary cutaneous CD30+ lymphoproliferative diseases Primary cutaneous anaplastic large cell lymphoma Lymphomatoid papulosis Subcutaneous panniculitis-like T-cell lymphoma Extranodal NK/T-cell lymphoma, nasal type Primary cutaneous peripheral T-cell lymphomaNotes
Glossary
Arrangement of cells around the vessels; perivascular.
Movement toward the epidermis, as in the migration of T lymphocytes into the epidermis in mycosis fungoides.
A process of detecting antigens (e.g., proteins) in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues
A process used to identify cells, based on the types of antigens or markers on the surface of the cell. This process is used to diagnose specific types of leukemia and lymphoma by comparing the cancer cells with normal cells of the immune system.
A well-defined collection of cells within the epidermis in T-cell lymphoma and mycosis fungoides.
A giant binucleated or multinucleated macrophage, characteristic of Hodgkin’s disease.
An atypical mononuclear cell seen in the peripheral blood in Sézary syndrome; has a large, convoluted nucleus and scant cytoplasm containing vacuoles that test positive with the periodic acid-Schiff stain.
References
- 1.Dummer R, Asagoe K, Cozzio A, Burg G, Doebbeling U, Golling P, et al. Recent advances in cutaneous lymphomas. J Dermatol Sci. 2007;48(3):157–67.CrossRefPubMedGoogle Scholar
- 2.Khamaysi Z, Ben-Arieh Y, Izhak OB, Epelbaum R, Dann EJ, Bergman R. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center. Am J Dermatopathol. 2008;30(1):37–44.CrossRefPubMedGoogle Scholar
- 3.Willemze R, Dreyling M, ESMO Guidelines Working Group. Primary cutaneous lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2010;21(Suppl 5):v177–80.CrossRefGoogle Scholar
- 4.Yamashita T, Abbade LPF, Marques MEA, Marques SA. Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update. An Bras Dermatol. 2012;87(6):817–28. quiz 829–30CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Doshi BR, Khopkar US. Retrospective study of spectrum of cutaneous lymphoma presenting to dermatology. Indian J Dermatol Venereol Leprol. 2011;77(4):512–5.CrossRefPubMedGoogle Scholar
- 6.Sokol L, Naghashpour M, Glass LF. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management. Cancer Control J Moffitt Cancer Cent. 2012;19(3):236–44.CrossRefGoogle Scholar
- 7.Vora R, Mubashir S, Talavia P, Anjaneyan G. Mycosis fungoides: tumour d’emblee. Indian Dermatol Online J. 2012;3(2):122–4.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Lee JH, Lee JH, Yoo DS, Kang H, Kim GM, Park HJ, et al. Characteristics of primary cutaneous lymphoma according to WHO-EORTC classification in Korea. Clin Exp Dermatol. 2013;38(5):457–63.CrossRefPubMedGoogle Scholar
- 9.Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91(1):151–65.CrossRefPubMedGoogle Scholar
- 10.Dummer R, Hess-Schmid M, Burg G. Cutaneous T-cell lymphomas: prognosis and quality-of-life issues. Clin Lymphoma. 2000;1(Suppl 1):S21–5.CrossRefPubMedGoogle Scholar
- 11.Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70(2):205.e1–16. quiz 221–2CrossRefGoogle Scholar
- 12.Mao X, Orchard G, Mitchell TJ, Oyama N, Russell-Jones R, Vermeer MH, et al. A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS. J Cutan Pathol. 2008;35(10):899–910.CrossRefPubMedGoogle Scholar
- 13.Hwang ST, Janik JE, Jaffe ES, Wilson WH. Mycosis fungoides and Sézary syndrome. Lancet Lond Engl. 2008;371(9616):945–57.CrossRefGoogle Scholar
- 14.Karenko L, Hahtola S, Päivinen S, Karhu R, Syrjä S, Kähkönen M, et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res. 2005;65(18):8101–10.CrossRefPubMedGoogle Scholar
- 15.Mao X, Orchard G, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, et al. Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis. J Invest Dermatol. 2006;126(6):1388–95.CrossRefPubMedGoogle Scholar
- 16.Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–85.CrossRefPubMedGoogle Scholar
- 17.Sanches JA Jr, Moricz CZM, Neto CF. Lymphoproliferative processes of the skin. Part 2 – Cutaneous T-cell and NK-cell lymphomas. An Bras Dermatol. 2006;81:7–25.CrossRefGoogle Scholar
- 18.Mirvish ED, Pomerantz RG, Geskin LJ. Infectious agents in cutaneous T-cell lymphoma. J Am Acad Dermatol. 2011;64(2):423–31.CrossRefPubMedGoogle Scholar
- 19.Ko CJ. The new World Health Organization–European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas. Adv Dermatol. 2006;22:259–77.CrossRefPubMedGoogle Scholar
- 20.Beylot-Barry M, Vergier B, Masquelier B, Bagot M, Joly P, Souteyrand P, et al. The spectrum of cutaneous lymphomas in HIV infection: a study of 21 cases. Am J Surg Pathol. 1999;23(10):1208–16.CrossRefPubMedGoogle Scholar
- 21.Morales-Suárez-Varela MM, Olsen J, Johansen P, Kaerlev L, Guénel P, Arveux P, et al. Occupational risk factors for mycosis fungoides: a European multicenter case-control study. J Occup Environ Med Am Coll Occup Environ Med. 2004;46(3):205–11.CrossRefGoogle Scholar
- 22.Morales-Suárez-Varela MM, Olsen J, Johansen P, Kaerlev L, Guénel P, Arveux P, et al. Occupational sun exposure and mycosis fungoides: a European multicenter case-control study. J Occup Environ Med Am Coll Occup Environ Med. 2006;48(4):390–3.CrossRefGoogle Scholar
- 23.Nicot C. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol. 2005;78(3):232–9.CrossRefPubMedGoogle Scholar
- 24.Khader A, Shaan M, Sasidharanpillai S, Pakran J, Rajan U. Adult T-cell leukemia/lymphoma: a retroviral malady. Indian J Dermatol. 2012;57(3):219–21.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Jang MS, Kang DY, Park JB, Kim ST, Suh KS. Cutaneous T-cell lymphoma in Asians. ISRN Dermatol. 2012;2012:575120.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Massone C, Chott A, Metze D, Kerl K, Citarella L, Vale E, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol. 2004;28(6):719–35.CrossRefPubMedGoogle Scholar
- 27.Hamada T, Nakamura S, Ko Y-H, Yoshino T, Ohshima K, Matsuzawa T, et al. Epstein-Barr virus-associated T/natural killer-cell lymphomas in the elderly: the first consensus meeting in Kofu 2013. J Dermatol. 2014;41(1):40–2.CrossRefPubMedGoogle Scholar
- 28.Guitart J. What’s new in cutaneous T-cell lymphomas: 2006. Semin Cutan Med Surg. 2006;25(2):87–90.CrossRefPubMedGoogle Scholar
- 29.Kempf W, Sander CA. Classification of cutaneous lymphomas – an update. Histopathology. 2010;56(1):57–70.CrossRefPubMedGoogle Scholar
- 30.Fernandez-Flores A. Comments on cutaneous lymphomas: since the WHO-2008 classification to present. Am J Dermatopathol. 2012;34(3):274–84.CrossRefPubMedGoogle Scholar
- 31.Nudelmann LM, Bonamigo RR. Primary cutaneous lymphoma in southern Brazil: a 12-year single-center experience. Int J Dermatol. 2015;54(12):e512–20.CrossRefPubMedGoogle Scholar
- 32.Querfeld C, Guitart J, Kuzel TM, Rosen ST. Primary cutaneous lymphomas: a review with current treatment options. Blood Rev. 2003;17(3):131–42.CrossRefPubMedGoogle Scholar
- 33.Dewar R, Andea AA, Guitart J, Arber DA, Weiss LM. Best practices in diagnostic immunohistochemistry: workup of cutaneous lymphoid lesions in the diagnosis of primary cutaneous lymphoma. Arch Pathol Lab Med. 2015;139(3):338–50.CrossRefPubMedGoogle Scholar
- 34.van Doorn R, Scheffer E, Willemze R. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch Dermatol. 2002;138(2):191–8.PubMedGoogle Scholar
- 35.Hodak E, Amitay I, Feinmesser M, Aviram A, David M. Ichthyosiform mycosis fungoides: an atypical variant of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2004;50(3):368–74.CrossRefPubMedGoogle Scholar
- 36.Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol JEADV. 2004;18(4):397–415.CrossRefPubMedGoogle Scholar
- 37.O’quinn RP, Zic JA, Boyd AS. Mycosis fungoides d’embleé: CD30-negative cutaneous large T-cell lymphoma. J Am Acad Dermatol. 2000;43(5 Pt 1):861–3.CrossRefPubMedGoogle Scholar
- 38.Clarijs M, Poot F, Laka A, Pirard C, Bourlond A. Granulomatous slack skin: treatment with extensive surgery and review of the literature. Dermatol Basel Switz. 2003;206(4):393–7.CrossRefGoogle Scholar
- 39.Mantaka P, Helsing P, Gjersvik P, Bassarova A, Clausen OPF, Delabie J. Clinical and histopathological features of folliculotropic mycosis fungoides: a Norwegian patient series. Acta Derm Venereol. 2013;93(3):325–9.CrossRefPubMedGoogle Scholar
- 40.Glusac EJ. Criterion by criterion, mycosis fungoides. Am J Dermatopathol. 2003;25(3):264–9.CrossRefPubMedGoogle Scholar
- 41.Zelger B, Sepp N, Weyrer K, Grünewald K, Zelger B. Syringotropic cutaneous T-cell lymphoma: a variant of mycosis fungoides? Br J Dermatol. 1994;130(6):765–9.CrossRefPubMedGoogle Scholar
- 42.Paulli M, Berti E. Cutaneous T-cell lymphomas (including rare subtypes). Curr Concepts II Haematol. 2004;89(11):1372–88.Google Scholar
- 43.Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(2):479–84.CrossRefPubMedGoogle Scholar
- 44.Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(6):1713–22.CrossRefPubMedGoogle Scholar
- 45.Rosen ST, Querfeld C. Primary cutaneous T-cell lymphomas. Hematol Am Soc Hematol Educ Program. 2006;323–30:513.Google Scholar
- 46.Weberschock T, Strametz R, Lorenz M, Röllig C, Bunch C, Bauer A, et al. Interventions for mycosis fungoides. Cochrane Database Syst Rev. 2012;9:CD008946.Google Scholar
- 47.Wilcox RA. Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014;89(8):837–51.CrossRefPubMedGoogle Scholar
- 48.Rallis E, Economidi A, Verros C, Papadakis P. Successful treatment of patch type mycosis fungoides with tacrolimus ointment 0.1%. J Drugs Dermatol JDD. 2006;5(9):906–7.PubMedGoogle Scholar
- 49.Alaibac M, Pigozzi B, Bordignon M. Is Sézary syndrome a true primary cutaneous lymphoma? Int J Dermatol. 2008;47(11):1195–6.CrossRefPubMedGoogle Scholar
- 50.Lundin J, Hagberg H, Repp R, Cavallin-Ståhl E, Fredén S, Juliusson G, et al. Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome. Blood. 2003;101(11):4267–72.CrossRefPubMedGoogle Scholar
- 51.Whittaker SJ, Marsden JR, Spittle M, Russell Jones R, British Association of Dermatologists, U.K. Cutaneous Lymphoma Group. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol. 2003;149(6):1095–107.CrossRefPubMedGoogle Scholar
- 52.Bittencourt AL, de Oliveira M de F. Cutaneous manifestations associated with HTLV-1 infection. Int J Dermatol. 2010;49(10):1099–110.CrossRefPubMedGoogle Scholar
- 53.Hermine O, Allard I, Lévy V, Arnulf B, Gessain A, Bazarbachi A, et al. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma. Hematol J Off J Eur Haematol Assoc EHA. 2002;3(6):276–82.Google Scholar
- 54.Yamada Y, Tomonaga M. The current status of therapy for adult T-cell leukaemia-lymphoma in Japan. Leuk Lymphoma. 2003;44(4):611–8.CrossRefPubMedGoogle Scholar
- 55.Nagasawa T, Miwa H, Nakatsuka S, Itami S, Yoshikawa K, Aozasa K. Characteristics of cutaneous lymphomas in Osaka, Japan (1988–1999) based on the European Organization for Research and Treatment of Cancer classification. Am J Dermatopathol. 2000;22(6):510–4.CrossRefPubMedGoogle Scholar
- 56.Cerroni L. Lymphoproliferative lesions of the skin. J Clin Pathol. 2006;59(8):813–26.CrossRefPubMedPubMedCentralGoogle Scholar
- 57.Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95(12):3653–61.PubMedGoogle Scholar
- 58.Väkevä L, Sarna S, Vaalasti A, Pukkala E, Kariniemi A-L, Ranki A. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides. Acta Derm Venereol. 2005;85(4):318–23.CrossRefPubMedGoogle Scholar
- 59.Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol. 1996;34(3):470–81.CrossRefPubMedGoogle Scholar
- 60.Hoque SR, Child FJ, Whittaker SJ, Ferreira S, Orchard G, Jenner K, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol. 2003;148(3):516–25.CrossRefPubMedGoogle Scholar
- 61.Marzano AV, Berti E, Paulli M, Caputo R. Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma: report of 7 cases. Arch Dermatol. 2000;136(7):889–96.CrossRefPubMedGoogle Scholar
- 62.Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155(2):483–92.CrossRefPubMedPubMedCentralGoogle Scholar
- 63.Toro JR, Liewehr DJ, Pabby N, Sorbara L, Raffeld M, Steinberg SM, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. 2003;101(9):3407–12.CrossRefPubMedGoogle Scholar